BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shin K, Jung EK, Park SJ, Jeong S, Kim IH, Lee MA. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy. World J Gastrointest Oncol 2021; 13(8): 915-928 [PMID: 34457195 DOI: 10.4251/wjgo.v13.i8.915]
URL: https://www.wjgnet.com/1948-5204/full/v13/i8/915.htm
Number Citing Articles
1
Danilo Hackner, Susanne Merkel, Andreas Weiß, Christian Krautz, Georg F. Weber, Robert Grützmann, Maximilian Brunner. Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre EvaluationCancers 2024; 16(16): 2911 doi: 10.3390/cancers16162911
2
Yu-qing Du, Xiu-mei Bai, Wei Yang, Zhong-yi Zhang, Song Wang, Wei Wu, Kun Yan, Min-hua Chen. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinomaInternational Journal of Hyperthermia 2022; 39(1): 517 doi: 10.1080/02656736.2022.2048907
3
Xiu-Yun Lu, Xi Guo, Qi Zhang, Yi-Jie Qiu, Dan Zuo, Sheng Chen, Xiao-Fan Tian, Yu-Hong Zhou, Yi Dong, Wen-Ping Wang. Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced UltrasoundDiagnostics 2022; 12(11): 2662 doi: 10.3390/diagnostics12112662
4
Jade Law, Harry Trieu, Guneet Kaleka, Joanna Turkiewicz, Samantha Palmer, Jennifer M. Lee, Kathryn T. Chen, James H. Tabibian. Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 LevelsCancers 2023; 15(6): 1723 doi: 10.3390/cancers15061723
5
Linjia Peng, Hao Chen. A novel nomogram and risk classification system based on inflammatory and immune indicators for predicting prognosis of pancreatic cancer patients with liver metastasesCancer Medicine 2023; 12(18): 18622 doi: 10.1002/cam4.6471
6
Mitesh J. Borad, Li‐Yuan Bai, Donald Richards, Kabir Mody, Joleen Hubbard, Sun Young Rha, John Soong, Daniel McCormick, Emmett Tse, Daniel O'Brien, Ahmad Bayat, Daniel Ahn, S. Lindsey Davis, Joon Oh. Park, Do‐Youn Oh. Silmitasertib plus gemcitabine and cisplatin first‐line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 studyHepatology 2023; 77(3): 760 doi: 10.1002/hep.32804
7
Makoto Kadokura, Keisuke Tanaka, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Nobuyuki Enomoto. Significance of Baseline and Changes of Tumor Markers and Neutrophil-to-Lymphocyte Ratio in Predicting Overall Survival for Patients with Advanced Pancreatic Adenocarcinoma: A Retrospective AnalysisJournal of Cancer Research and Practice 2023; 10(2): 57 doi: 10.4103/ejcrp.eJCRP-D-22-00036
8
Kian Heshmat-Ghahdarijani, Vida Sarmadi, Afshin Heidari, Alireza Falahati Marvasti, Sina Neshat, Sina Raeisi. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative reviewFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1228076
9
Monika Kapszewicz, Ewa Małecka-Wojciesko. Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?Journal of Clinical Medicine 2021; 10(22): 5463 doi: 10.3390/jcm10225463
10
Hillary G. Pratt, Kayla J. Steinberger, Nicole E. Mihalik, Sascha Ott, Thomas Whalley, Barbara Szomolay, Brian A. Boone, Timothy D. Eubank. Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic CancerCancers 2021; 14(1): 194 doi: 10.3390/cancers14010194